RZG
Invesco S&P Smallcap 600 Pure Growth ETF
SMB
Adj. R2
0.910
Rel. Sharpe
0.886
Mkt beta
1.01
AUM
US$111M
MER
0.35%
Valuation
113
ETF comparison
Verified factor-similar pair
RZG vs SCHM
These two ETFs meet the same FF6 US comparison criteria: US-listed equity ETFs, the same USD model basis, at least one material non-market factor, and 100% overlap in statistically significant material factor exposure.
SMB
Similarity score
83
Verified similar
The score combines exposure-level distance, factor-vector shape, market-beta closeness, and a small backtested relative-Sharpe term.
Quick Read
- SCHM has the higher backtested relative Sharpe (0.918 vs 0.886).
- SCHM has the lower published fee (0.04% vs 0.35%).
- RZG is cheaper on dividend valuation (113 vs 116, where 100 is each fund's historical median).
- SCHM has the stronger regression fit (adjusted R-squared 0.947 vs 0.910).
These are screening signals, not a complete review of portfolio construction, turnover, taxes, or trading quality.
SCHM
Schwab U.S. Mid-Cap ETF
SMB
Adj. R2
0.947
Rel. Sharpe
0.918
Mkt beta
1.02
AUM
US$13.6B
MER
0.04%
Valuation
116
Factor Exposure Match
Blue bars compare raw factor beta magnitude. Green bars compare absolute t-stat strength. Dim bars indicate the t-stat is below 1.96.
SMB
diff +0.56
HML
diff -0.07
RMW
diff +0.10
CMA
diff -0.08
UMD
diff -0.03
Why This Pair Matches
Exposure level
77
Exposure shape
98
Mkt beta diff
0.02
Rel. Sharpe diff
0.031
This comparison focuses on measured factor exposure. It does not compare holdings methodology, turnover, tax handling, or issuer process. Backtested relative Sharpe is a secondary signal rather than a stand-alone forecast. See methodology.
Monthly updates
Get the next US ETF leaders update
Get one monthly email when the US leaders table refreshes, plus methodology and comparison-page updates.
Monthly leaders refresh
Download-access updates
Low-volume research notes
One monthly email when the data drop lands. This browser will remember you after signup.